Single Cell Omics Market & Business Tutorial
Presented by Steven Bodovitz, Ph.D.
Select Biosciences invites you to attend a half-day interactive market analysis and business strategy tutorial presented by Steven Bodovitz, Ph.D and co-located with the Single Cell Analysis Congress. The tutorial is based on the detailed market and technology analysis report and the Trends in Biotechnology cover article written by Dr. Bodovitz (BioPerspectives) and Dr. Daojing Wang (Lawrence Berkeley National Laboratory). The report is titled Single Cell Analysis 2010: the New Frontier for ’Omics, and the cover article is similarly titled Single Cell Analysis: the New Frontier in ‘Omics’. The report was published in January 2010 and the cover article is in press (doi:10.1016/j.tibtech.2010.03.002).
Dr. Bodovitz has been continually tracking opportunities and challenges for ’omics for more than a decade. During this period, the main challenge has been making sense of the deluge of ’omics data that underscores the complexity of biological systems. The main opportunity is simplifying these data, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into irrelevance. ’Omics technologies, such as DNA sequencing, PCR (and related), micro/nano arrays/particles, micro/nanofluidics and mass spectrometry, are beginning to be used to analyze genes, proteins and metabolites in single cells, and beginning to meet the significant demand in applications such as cancer biology, stem cell biology, neurobiology, synthetic biology and biofuel and drug development, where understanding and manipulating the full complexity of intracellular pathways is the goal. ’Omics-based single cell analysis is a new market opportunity that is projected to grow from $70 million in sales in 2009 to more than $575 million in 2015.
Successful conversion of opportunity to profit requires a detailed understanding of this emerging market. The tutorial will cover the key technologies, applications, unmet needs and trends. The tutorial will include key findings from interviews with experts, a survey with more than 300 respondents, analyses of 25 companies and 16 academic programs and a 5-by-7 quantitative market model of technologies and applications. Moreover, the tutorial will include key insights and networking opportunities with fellow participants.
Who Should Attend
- Scientists at Pharmaceutical and Biotechnology companies and in Academia
- Business Development, Licensing and Marketing Executives at Pharmaceutical and Biotechnology companies
- Licensing and Technology Transfer Executives from Academic Institutions
- Established and start-up companies in ’omics and fluidics
- Investors seeking emerging and established opportunities in single cell analysis